The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Category: Health Industry
Battle Lines Are Drawn Over California Deal With Kaiser Permanente
A controversial proposal to grant HMO giant Kaiser Permanente a no-bid statewide Medicaid contract is headed for its first legislative hearing amid vocal opposition from a coalition of counties, competing health plans, community clinics, and a national health care labor union.
Attendance Plummets at LA Covid Vaccination Events
Across Los Angeles County, few people are showing up at covid vaccination drives even though nearly 2 million residents remain unvaccinated.
It’s Not Just Doctors and Nurses. Veterinarians Are Burning Out, Too.
Empathy overload and compassion fatigue contribute to the mental health woes of veterinarians, who are more likely than other Americans to attempt suicide. And with 23 million families adopting pets during the pandemic, vets’ stress burden is no doubt heavier now.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN’s ‘What the Health?’: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Private Equity Ownership of Nursing Homes Triggers Capitol Hill Questions — And a GAO Probe
In his State of the Union address, President Joe Biden decried these financial arrangements, which two members of the powerful House Ways and Means Committee had already asked the Government Accountability Office to investigate.
Profit Strategy: Psychiatric Facilities Prioritize Out-of-State Kids
Nearly all psychiatric residential treatment centers for children in South Carolina operate as for-profit businesses — some backed by private equity — and many prioritize out-of-state kids because it’s better for the bottom line. The scramble to secure treatment for children and teenagers has become so competitive that South Carolina will spend millions more each year as of April 1 to keep out-of-state patients from flooding the state’s treatment facilities.
California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.
The company awarded the state’s Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn’t pick — one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.
Never-Ending Costs: When Resolved Medical Bills Keep Popping Up
A bill one family considered paid wrongfully resurfaced, resurrecting painful memories. It’s a scenario that’s not uncommon but grievously unsettling.
